Peer-reviewedCC BY-NC-NDJournal of thoracic disease28 Aug 2026

Prognostic impact of neoadjuvant therapy and nomogram development in early-stage and locally advanced Siewert type II adenocarcinoma of the esophagogastric junction based on the SEER database

Pubo Shi¹
Pengjie Yang²
Xingfu Ban³
Yong Li⁴
Benben Zhu¹

4 affiliations

¹College of Pharmacy , Inner Mongolia Medical University , Hohhot , ;
²Department of Thoracic Surgery , Peking University Cancer Hospital (Inner Mongolia Campus)/Affiliated Cancer Hospital of Inner Mongolia Medical University , Hohhot , ;
³Department of Thoracic Surgery , The Affiliated Hospital of Southwest Medical University , Luzhou , ;
⁴Department of Thoracic Surgery , National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital , Peking Union Medical College , Chinese Academy of Medical Sciences , Beijing , ;

Read full text PDF Cite

Neoadjuvant toripalimab plus concurrent chemoradiotherapy for locally advanced adenocarcinoma of the esophagogastric junction: a phase II trial
Yongheng Li, Rongxu Du, Jianhao Geng +25
BMC Medicine20 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Surgery & anaesthesiaCrossref
Can the prognostic nutritional index predict survival in patients with gastric and esophagogastric junction adenocarcinoma?
Mehmet Furkan Sağdıç, Burak Dinçer, Güldeniz Argun +2
Frontiers in Oncology22 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
Development and validation of a postoperative prognostic nomogram for early-stage pancreatic cancer
Pengcheng Cai, Chao Luo, Liangsong Zhao +2
Scientific Reports24 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
Development and validation of a nomogram predicting pathologic complete response to neoadjuvant chemotherapy in luminal type breast cancer patients using MammaPrint® and clinicopathological factor
Sarah Al safi, Tae Kyung Yoo, Jisun Kim +6
PLOS One21 Sep 2026Peer-reviewedCC BY 4.0Full textOncologyPLOS
Association of High-Grade Components < 20% on DFS in Stage I Lung Adenocarcinoma: A Real-World Study of Risk Analysis and Predictive Nomogram Development.
Shuhao Liang, Xuanpeng Wu, Tao Jiang +7
Cancer medicine1 Nov 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC

Cite

BibTeX RIS

BibTeX

@article{shi2026prognostic,
  title = {{Prognostic impact of neoadjuvant therapy and nomogram development in early-stage and locally advanced Siewert type II adenocarcinoma of the esophagogastric junction based on the SEER database}},
  author = {Pubo Shi and Pengjie Yang and Xingfu Ban and Yong Li and Benben Zhu},
  journal = {Journal of thoracic disease},
  year = {2026},
  month = aug,
  url = {https://europepmc.org/article/PMC/PMC13655897},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Prognostic impact of neoadjuvant therapy and nomogram development in early-stage and locally advanced Siewert type II adenocarcinoma of the esophagogastric junction based on the SEER database
AU  - Pubo Shi
AU  - Pengjie Yang
AU  - Xingfu Ban
AU  - Yong Li
AU  - Benben Zhu
PY  - 2026
DA  - 2026/08/28
JO  - Journal of thoracic disease
UR  - https://europepmc.org/article/PMC/PMC13655897
SN  - 2072-1439
SN  - 2077-6624
ER  -

Related

Cite